##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 1 Download : 0

##plugins.themes.academic_pro.article.main##

Abstract

The clinical pharmacological approach to the rational drug treatment of chronic heart failure (CHF) focuses on optimizing therapeutic strategies to improve patient outcomes. This article examines the pharmacological classes of drugs used in CHF management, including angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, aldosterone antagonists, and novel agents. The mechanisms of action, indications, contraindications, and potential adverse effects of these drugs are analyzed. Special emphasis is placed on the importance of individualized treatment, drug interactions, and evidence-based guidelines. Advances in pharmacotherapy and personalized medicine approaches for enhancing the efficacy and safety of CHF treatment are also discussed.

Keywords

Chronic heart failure rational pharmacotherapy clinical pharmacology

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Bazarova A.M. (2025). Clinical Pharmacological Approach To Rational Drug Treatment Of Chronic Heart Failure. Texas Journal of Medical Science, 42, 45–47. Retrieved from https://zienjournals.com/index.php/tjms/article/view/6015

References

  1. Alyavi A.L., Kamilova U.K., Rasulova D.Z. Diagnosis and treatment of chronic heart failure.
  2. Tashkent 2016. P.196.
  3. Cardiology in diagrams and tables, translation from English. M., 2013.
  4. Kukes V.G. Clinical pharmacology. M., 2018. 936 b.
  5. Larina V.N., Skiba I.K., Skiba A.S. Brief review of updates to clinical guidelines for chronic heart
  6. failure of the European Society of Cardiology 2021. Russian Journal of Cardiology
  7. ;27(2):4820:97-105. doi:10.15829/ 1560-4071-2022-482.
  8. Saidova Sh.A., Yakubov A.V., Pulatova N.I. “Clinical pharmacology of cardiotonic drugs” 2017.